Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia. [PDF]
ElifeJoseph RE +7 more
europepmc +1 more source
B cell receptor signaling in autoimmune rheumatic diseases: regulatory mechanisms and therapeutic targeting. [PDF]
Front ImmunolZhu Y +11 more
europepmc +1 more source
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis. [PDF]
J Transl MedSu QY +8 more
europepmc +1 more source
Towards Treating Multiple Sclerosis Progression. [PDF]
Pharmaceuticals (Basel)Häusler D, Weber MS.
europepmc +1 more source
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon. [PDF]
Clin Kidney JRoberts L, Barratt J.
europepmc +1 more source
Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond. [PDF]
J Allergy Clin Immunol PractHsu FI +3 more
europepmc +1 more source
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success. [PDF]
Curr Opin NeurolCree B, Hartung HP.
europepmc +1 more source
Epstein-Barr virus associated diseases: Immune alterations and targeted approaches. [PDF]
Front ImmunolCao S, Xiong J, Zhao J, Zhao WL.
europepmc +1 more source
Targeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies. [PDF]
CellsBravo E +4 more
europepmc +1 more source
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments. [PDF]
Pharmaceuticals (Basel)Asero R, Calzari P, Vaienti S, Cugno M.
europepmc +1 more source